Projects

Wyss Zurich News

Find out about the latest news and what’s happening at Wyss Zurich! Learn more about the status of our current projects and stay informed about our alumni projects and related startups.

Featured News

Annual Event 10 Years Wyss Zurich

Wyss Zurich celebrated its 10th anniversary at the Annual Event on November 3rd 2025. Over 300 guests gathered at the Kongresshaus Zurich to celebrate 10 years of impact by the Wyss Zurich Translational Center.

All News

Filtered (15)
Filters
Filter by Projects
Show (15)
Cancel

Interview: Dr. Ana Montalban-Arques on Adularia’s Strategic Transition to Molecular Cancer Treatments

A lot changes in the first few years of a startup. This was also the case at Adularia, formerly Recolony: a discovery in the laboratory led to a new focus, which resulted in the repositioning of the entire company.

Recolony AG becomes Adularia AG

Recolony is now Adularia. This change reflects an important shift in the company’s strategic direction and an ongoing commitment to advancing cancer treatments.

Recolony AG announced as winner of the TOP100 Public Voting biotech

Public voting confirms the biotech startup’s technology resonates with the public.

TOP 100 Swiss Startup Awards: Wyss Zurich Highlights

Discover the world shapers of tomorrow.

X-Health.show: Treating Cancer with Bacteria with Dr. Ana Montalban-Arques, Recolony

Alex Jani, host of X-Health.show podcast spoke with our project leader from Recolony, Ana Montalban-Arques about the science behind Recolony.

Founded.ch – Recolony entwickelt die natürliche Alternative zur Chemotherapie

Die Krebsbekämpfung steht vor einer Revolution. Recolony hat das Potenzial spezieller Darmbakterien erkannt und entwickelt aktuell eine vielversprechende Therapie, die hohe Heilungschancen und geringe Nebenwirkungen verspricht.

Swisspreneur Podcast – Ana Montalban-Arques: Treating Cancer with Bacteria

Ana Montalban-Arques⁠ is co-founder and CEO of ⁠Recolony⁠, a biotech startup developing a bacteria-based oral therapy to treat cancer.

Recolony identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors

Recolony has been identified as one of the 15 most promising Swiss biotech startups of 2023, according to investors.

Wyss Zurich current and alumni projects on stage at TOP100 Startup Awards 2023

Fantastic presence of current and alumni Wyss Zurich projects at TOP 100 Swiss Startup Award! ANYbotics (ANYmotion) and CUTISS (denovoSkin) again first respectively on Robotics and Biotech Scale-up ranking, MUVON positioned at the top among the fourty-one newcomers and made the third place on Biotech Startup ranking.

Sign up for our newsletter!

For newsletter distribution, your email address will be processed by a GDPR-certified service provider. Further information can be found in our privacy policy.

Got a Breakthrough Idea? Let’s build the future together.

At Wyss Zurich, we helpt entrepreneurial teams from ETH Zurich and University of Zurich transform their projects in a real-world solution. Contact us to learn more about our application process.

Contact Form
Learn more